English
Insider transactions
EDGARTenax Therapeutics, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 20 transactions, 3,699,112 shares
- Sum of shares × price per share: 6,496,808.8071
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–34 of 34
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-21 Filed 2026-10-21 | ADAR1 Capital Management, LLC 10% ownerSchneeberger Daniel 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 331,979 | 1.6588 | 550,686.7652Derived: shares × price per share. Exact value 550686.7652. | 7,447,000 | Indirect (I) See Footnote | No | F3, F4, F5
| Open filing 0001940272-26-000027 Read from the filing’s XML Dispute this row |
| 2026-10-20 Filed 2026-10-21 | ADAR1 Capital Management, LLC 10% ownerSchneeberger Daniel 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 254,342 | 1.5952 | 405,726.3584Derived: shares × price per share. Exact value 405726.3584. | 7,115,021 | Indirect (I) See Footnote | No | F2, F4, F5
| Open filing 0001940272-26-000027 Read from the filing’s XML Dispute this row |
| 2026-10-19 Filed 2026-10-21 | ADAR1 Capital Management, LLC 10% ownerSchneeberger Daniel 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 336,528 | 1.5066 | 507,013.0848Derived: shares × price per share. Exact value 507013.0848. | 6,860,679 | Indirect (I) See Footnote | No | F1, F4, F5
| Open filing 0001940272-26-000027 Read from the filing’s XML Dispute this row |
| 2026-09-16 Filed 2026-09-17 | Doogan Declan Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 53,000 | 1.92 | 101,760Derived: shares × price per share. Exact value 101760.00. | 55,274 | Direct (D) | No | — | Open filing 0001193125-26-394831 Read from the filing’s XML Dispute this row |
| 2026-09-15 Filed 2026-09-15 | Giordano Christopher Thomas Director · Officer: CEO | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 4,850 | 1.8221 | 8,837.185Derived: shares × price per share. Exact value 8837.1850. | 22,174 | Direct (D) | No | F2
| Open filing 0001871714-26-000002 Read from the filing’s XML Dispute this row |
| 2026-09-11 Filed 2026-09-15 | STAAB THOMAS R II Officer: Chief Financial Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 5,675 | 1.935 | 10,981.125Derived: shares × price per share. Exact value 10981.125. | 15,675 | Direct (D) | No | F1
| Open filing 0001193125-26-392319 Read from the filing’s XML Dispute this row |
| 2026-09-11 Filed 2026-09-15 | Giordano Christopher Thomas Director · Officer: CEO | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 6,000 | 1.875 | 11,250Derived: shares × price per share. Exact value 11250.000. | 17,324 | Direct (D) | No | F1
| Open filing 0001871714-26-000002 Read from the filing’s XML Dispute this row |
| 2026-09-03 Filed 2026-09-08 | ADAR1 Capital Management, LLC 10% ownerSchneeberger Daniel 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 900,000 | 1.7824 | 1,604,160Derived: shares × price per share. Exact value 1604160.0000. | 6,524,151 | Indirect (I) See Footnote | No | F1, F2, F3
| Open filing 0001940272-26-000020 Read from the filing’s XML Dispute this row |
| 2026-09-02 Filed 2026-09-02 | ADAR1 Capital Management, LLC 10% ownerSchneeberger Daniel 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 187,704 | 1.7985 | 337,585.644Derived: shares × price per share. Exact value 337585.6440. | 5,624,151 | Indirect (I) See Footnote | No | F3, F4, F5
| Open filing 0001940272-26-000019 Read from the filing’s XML Dispute this row |
| 2026-09-01 Filed 2026-09-02 | ADAR1 Capital Management, LLC 10% ownerSchneeberger Daniel 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 179,058 | 1.7959 | 321,570.2622Derived: shares × price per share. Exact value 321570.2622. | 5,436,447 | Indirect (I) See Footnote | No | F2, F4, F5
| Open filing 0001940272-26-000019 Read from the filing’s XML Dispute this row |
| 2026-08-31 Filed 2026-09-02 | ADAR1 Capital Management, LLC 10% ownerSchneeberger Daniel 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 403,571 | 1.7905 | 722,593.8755Derived: shares × price per share. Exact value 722593.8755. | 5,257,389 | Indirect (I) See Footnote | No | F1, F4, F5
| Open filing 0001940272-26-000019 Read from the filing’s XML Dispute this row |
| 2026-08-24 Filed 2026-08-24 | ADAR1 Capital Management, LLC 10% ownerSchneeberger Daniel 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 107,374 | 1.7542 | 188,355.4708Derived: shares × price per share. Exact value 188355.4708. | 4,853,818 | Indirect (I) See Footnote | No | F3, F4, F5
| Open filing 0001940272-26-000017 Read from the filing’s XML Dispute this row |
| 2026-08-21 Filed 2026-08-24 | ADAR1 Capital Management, LLC 10% ownerSchneeberger Daniel 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 716,369 | 1.7676 | 1,266,253.8444Derived: shares × price per share. Exact value 1266253.8444. | 4,746,444 | Indirect (I) See Footnote | No | F2, F4, F5
| Open filing 0001940272-26-000017 Read from the filing’s XML Dispute this row |
| 2026-08-20 Filed 2026-08-24 | ADAR1 Capital Management, LLC 10% ownerSchneeberger Daniel 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 202,124 | 1.7788 | 359,538.1712Derived: shares × price per share. Exact value 359538.1712. | 4,030,075 | Indirect (I) See Footnote | No | F1, F4, F5
| Open filing 0001940272-26-000017 Read from the filing’s XML Dispute this row |
| 2026-07-13 Filed 2026-07-14 | Giordano Christopher Thomas Director · Officer: CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 219 | 3.549 | 777.231Derived: shares × price per share. Exact value 777.231. | 2,824 | Direct (D) | No | F1
| Open filing 0001193125-26-303600 Read from the filing’s XML Dispute this row |
| 2026-07-13 Filed 2026-07-14 | Giordano Christopher Thomas Director · Officer: CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 8,500 | 5.94 | 50,490Derived: shares × price per share. Exact value 50490.00. | 11,324 | Direct (D) | No | F1
| Open filing 0001193125-26-303600 Read from the filing’s XML Dispute this row |
| 2026-07-13 Filed 2026-07-14 | Giordano Christopher Thomas Director · Officer: CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 219 | 0 | — | 218 | Direct (D) | No | F2
| Open filing 0001193125-26-303600 Read from the filing’s XML Dispute this row |
| 2026-07-13 Filed 2026-07-14 | Giordano Christopher Thomas Director · Officer: CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 8,500 | 0 | — | 1,241,500 | Direct (D) | No | — | Open filing 0001193125-26-303600 Read from the filing’s XML Dispute this row |
| 2026-05-11 Filed 2026-05-13 | STAAB THOMAS R II Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 10,000 | 0 | — | 10,000 | Direct (D) | No | F1
| Open filing 0001193125-26-221926 Read from the filing’s XML Dispute this row |
| 2026-05-11 Filed 2026-05-13 | STAAB THOMAS R II Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 450,000 | 0 | — | 450,000 | Direct (D) | No | F2
| Open filing 0001193125-26-221926 Read from the filing’s XML Dispute this row |
| 2026-01-30 Filed 2026-02-03 | MCGAULEY THOMAS Officer: Interim CFO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0001550701-26-000001 Read from the filing’s XML Dispute this row |
| 2026-01-09 Filed 2026-01-13 | Hunter Robyn Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 30,000 | 0 | — | 30,000 | Direct (D) | No | — | Open filing 0001713932-26-000001 Read from the filing’s XML Dispute this row |
| 2026-01-09 Filed 2026-01-13 | Rich Stuart Director · Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 250,000 | 0 | — | 250,000 | Direct (D) | No | F4
| Open filing 0001841785-26-000001 Read from the filing’s XML Dispute this row |
| 2026-01-09 Filed 2026-01-13 | Doogan Declan Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 30,000 | 0 | — | 30,000 | Direct (D) | No | — | Open filing 0001704234-26-000001 Read from the filing’s XML Dispute this row |
| 2026-01-09 Filed 2026-01-13 | Almenoff June Sherie Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 30,000 | 0 | — | 30,000 | Direct (D) | No | — | Open filing 0001492647-26-000001 Read from the filing’s XML Dispute this row |
| 2026-01-09 Filed 2026-01-13 | Giordano Christopher Thomas Director · Officer: CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 450,000 | 0 | — | 450,000 | Direct (D) | No | F1
| Open filing 0001871714-26-000001 Read from the filing’s XML Dispute this row |
| 2026-01-09 Filed 2026-01-13 | Davidson Michael H. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 30,000 | 0 | — | 30,000 | Direct (D) | No | — | Open filing 0001573785-26-000001 Read from the filing’s XML Dispute this row |
| 2026-01-09 Filed 2026-01-13 | PROEHL GERALD T Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,000 | 0 | — | 30,000 | Direct (D) | No | — | Open filing 0001279191-26-000001 Read from the filing’s XML Dispute this row |
| 2025-12-09 Filed 2025-12-10 | Rich Stuart Director · Officer: Chief Medical Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 2,500 | 10.2168 | 25,542Derived: shares × price per share. Exact value 25542.0000. | 5,266 | Direct (D) | No | F3
| Open filing 0001841785-25-000004 Read from the filing’s XML Dispute this row |
| 2025-12-08 Filed 2025-12-10 | Rich Stuart Director · Officer: Chief Medical Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 2,500 | 10.1002 | 25,250.5Derived: shares × price per share. Exact value 25250.5000. | 5,000 | Indirect (I) By Stuart Rich Revocable Trust DTD 11/18/1996 | No | F1, F2
| Open filing 0001841785-25-000004 Read from the filing’s XML Dispute this row |
| 2025-12-04 Filed 2025-12-05 | Rich Stuart Director · Officer: Chief Medical Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 2,500 | 9.1992 | 22,998Derived: shares × price per share. Exact value 22998.0000. | 2,500 | Indirect (I) By Stuart Rich Revocable Trust DTD 11/18/1996 | No | F3, F4
| Open filing 0001841785-25-000003 Read from the filing’s XML Dispute this row |
| 2025-12-03 Filed 2025-12-05 | Rich Stuart Director · Officer: Chief Medical Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,500 | 9.0786 | 13,617.9Derived: shares × price per share. Exact value 13617.9000. | 2,766 | Direct (D) | No | F2
| Open filing 0001841785-25-000003 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-05 | Rich Stuart Director · Officer: Chief Medical Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,000 | 9.0059 | 9,005.9Derived: shares × price per share. Exact value 9005.9000. | 1,266 | Direct (D) | No | F1
| Open filing 0001841785-25-000003 Read from the filing’s XML Dispute this row |
| 2025-11-20 Filed 2025-11-20 | Giordano Christopher Thomas Director · Officer: CEO | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 538 | 7.5887 | 4,082.7206Derived: shares × price per share. Exact value 4082.7206. | 2,605 | Direct (D) | No | F3
| Open filing 0001871714-25-000002 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.
Showing 1–50 of 124
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 6,524,151 SH | 12,330,645 dollars | Higher by 6,303,689 Prior quarter: 220,462 | Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 2,805,496 SH | 5,302,387 dollars | Higher by 1,077,508 Prior quarter: 1,727,988 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| Vivo Capital, LLC | 2,500,000 SH | 4,725,000 dollars | Unchanged Prior quarter: 2,500,000 | Open filing 0001213900-26-119459 Filed 2026-11-13 Dispute this row |
| SPHERA FUNDS MANAGEMENT LTD. Partly reported under another manager | 2,315,696 SH | 4,376,665 dollars | Higher by 2,195,496 Prior quarter: 120,200 | Open filing 0001496201-26-000006 Filed 2026-11-16 Dispute this row |
| MARSHALL WACE, LLP Partly reported under another manager | 1,779,564 SH | 3,363,374 dollars | Higher by 1,193,986 Prior quarter: 585,578 | Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row |
| MILLENNIUM MANAGEMENT LLC | 1,362,730 SH | 2,575,560 dollars | Higher by 486,500 Prior quarter: 876,230 | Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row |
| AQR CAPITAL MANAGEMENT LLC Partly reported under another manager | 1,252,703 SH | 2,367,609 dollars | Not in the prior quarter’s filings read | Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,131,973 SH | 2,139,429 dollars | Lower by 15,148 Prior quarter: 1,147,121 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 942,937 SH | 1,782,152 dollars | Higher by 510,717 Prior quarter: 432,220 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 864,596 SH | 1,634,455 dollars | Higher by 225,059 Prior quarter: 639,537 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| JANE STREET GROUP, LLC Partly reported under another manager | 689,312 SH | 1,302,799 dollars | Higher by 422,656 Prior quarter: 266,656 | Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 627,023 SH | 1,185,073 dollars | Higher by 352,077 Prior quarter: 274,946 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| Stonepine Capital Management, LLC | 588,000 SH | 1,111,320 dollars | Lower by 72,000 Prior quarter: 660,000 | Open filing 0001440771-26-000027 Filed 2026-11-13 Dispute this row |
| BRAIDWELL LP | 584,412 SH | 1,104,539 dollars | Unchanged Prior quarter: 584,412 | Open filing 0001420506-26-002894 Filed 2026-11-16 Dispute this row |
| WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager | 555,995 SH | 1,050,830 dollars | Higher by 460,482 Prior quarter: 95,513 | Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 535,410 SH | 1,011,925 dollars | Higher by 24,596 Prior quarter: 510,814 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| FMR LLC Partly reported under another manager | 533,217 SH | 1,007,780 dollars | Lower by 3,409,156 Prior quarter: 3,942,373 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| Caitong International Asset Management Co., Ltd | 489,906 SH | 925,922 dollars | Higher by 489,756 Prior quarter: 150 | Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager | 428,063 SH | 809,039 dollars | Higher by 138,899 Prior quarter: 289,164 | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 409,733 SH | 774,395 dollars | Lower by 130,393 Prior quarter: 540,126 | Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row |
| Balyasny Asset Management L.P. | 369,587 SH | 698,519 dollars | Not in the prior quarter’s filings read | Open filing 0001193125-26-463223 Filed 2026-11-16 Dispute this row |
| Ikarian Capital, LLC Option: Call | 356,600 SH | 673,974 dollars | Lower by 16,500 Prior quarter: 373,100 | Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row |
| TORONTO DOMINION BANK Option: Call Partly reported under another manager | 327,000 SH | 618,030 dollars | Not in the prior quarter’s filings read | Open filing 0002052595-26-000123 Filed 2026-11-16 Dispute this row |
| Caption Management, LLC Option: Call | 299,600 SH | 566,244 dollars | Lower by 100,100 Prior quarter: 399,700 | Open filing 0001706766-26-000008 Filed 2026-11-16 Dispute this row |
| Qube Research Technologies Ltd | 280,621 SH | 530,374 dollars | Lower by 149,272 Prior quarter: 429,893 | Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row |
| UBS Group AG Partly reported under another manager | 274,223 SH | 518,282 dollars | Higher by 176,080 Prior quarter: 98,143 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| PRUDENTIAL FINANCIAL INC Partly reported under another manager | 249,695 SH | 471,924 dollars | Not in the prior quarter’s filings read | Open filing 0001137774-26-000233 Filed 2026-11-16 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 247,776 SH | 468,297 dollars | Higher by 78,935 Prior quarter: 168,841 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| Quadrature Capital Ltd Partly reported under another manager | 238,886 SH | 451,495 dollars | Not in the prior quarter’s filings read | Open filing 0001651424-26-000014 Filed 2026-11-13 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 234,818 SH | 443,806 dollars | Higher by 35,684 Prior quarter: 199,134 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| Ensign Peak Advisors, Inc | 234,205 SH | 442,647 dollars | Higher by 57,316 Prior quarter: 176,889 | Open filing 0001454984-26-000011 Filed 2026-11-12 Dispute this row |
| Nuveen, LLC Partly reported under another manager | 215,359 SH | 407,029 dollars | Higher by 54,172 Prior quarter: 161,187 | Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 212,850 SH | 402,287 dollars | Higher by 55,808 Prior quarter: 157,042 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| Walleye Capital LLC | 204,144 SH | 385,832 dollars | Higher by 98,907 Prior quarter: 105,237 | Open filing 0001758720-26-000007 Filed 2026-11-13 Dispute this row |
| CITIGROUP INC Partly reported under another manager | 175,348 SH | 331,407 dollars | Higher by 163,725 Prior quarter: 11,623 | Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row |
| CITADEL ADVISORS LLC Option: Call Partly reported under another manager | 167,300 SH | 316,197 dollars | Higher by 36,900 Prior quarter: 130,400 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager | 166,800 SH | 315,252 dollars | Higher by 70,000 Prior quarter: 96,800 | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| JANE STREET GROUP, LLC Option: Call Partly reported under another manager | 157,500 SH | 297,675 dollars | Higher by 17,100 Prior quarter: 140,400 | Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row |
| LMR Partners LLP | 150,489 SH | 284,424 dollars | Not in the prior quarter’s filings read | Open filing 0001578621-26-000193 Filed 2026-11-16 Dispute this row |
| Ikarian Capital, LLC | 136,648 SH | 258,265 dollars | Lower by 650,952 Prior quarter: 787,600 | Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row |
| SPHERA FUNDS MANAGEMENT LTD. Option: Call Partly reported under another manager | 127,600 SH | 241,164 dollars | Unchanged Prior quarter: 127,600 | Open filing 0001496201-26-000006 Filed 2026-11-16 Dispute this row |
| BARCLAYS PLC Partly reported under another manager | 124,205 SH | 234,748 dollars | Higher by 116,151 Prior quarter: 8,054 | Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row |
| Jones Hill Capital LP | 122,169 SH | 230,899 dollars | Not in the prior quarter’s filings read | Open filing 0002102314-26-000006 Filed 2026-11-13 Dispute this row |
| BOOTHBAY FUND MANAGEMENT, LLC Option: Call | 106,100 SH | 200,529 dollars | Lower by 5,000 Prior quarter: 111,100 | Open filing 0001549230-26-000012 Filed 2026-11-16 Dispute this row |
| JANE STREET GROUP, LLC Option: Put Partly reported under another manager | 100,900 SH | 190,701 dollars | Higher by 85,400 Prior quarter: 15,500 | Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row |
| Engineers Gate Manager LP | 99,996 SH | 188,992 dollars | Not in the prior quarter’s filings read | Open filing 0001620220-26-000010 Filed 2026-11-16 Dispute this row |
| SIMPLEX TRADING, LLC Option: Call | 94,200 SH | 178,038 dollars | Lower by 53,300 Prior quarter: 147,500 | Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row |
| Caption Management, LLC | 93,005 SH | 175,779 dollars | Lower by 161,995 Prior quarter: 255,000 | Open filing 0001706766-26-000008 Filed 2026-11-16 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 89,743 SH | 169,614 dollars | Higher by 28,569 Prior quarter: 61,174 | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| Bank of New York Mellon Corp Partly reported under another manager | 84,079 SH | 158,909 dollars | Lower by 241,217 Prior quarter: 325,296 | Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- PERCEPTIVE ADVISORS LLC 1,700,000 SH
- Candriam S.C.A. 749,588 SH
- CITADEL ADVISORS LLC 728,561 SH
- RTW INVESTMENTS, LP 696,570 SH
- Point72 Asset Management, L.P. 556,761 SH
- Velan Capital Investment Management LP 549,985 SH
- Woodline Partners LP 531,254 SH
- Sofinnova Investments, Inc. 500,039 SH
- Jupiter Topco LLC 451,226 SH
- Siren, L.L.C. 427,141 SH
- Trexquant Investment LP 321,604 SH
- DIADEMA PARTNERS LP 307,000 SH
- Logos Global Management LP 300,000 SH
- Avidity Partners Management LP 265,934 SH
- Balyasny Asset Management L.P. 194,000 SH
- ExodusPoint Capital Management, LP 184,501 SH
- Integral Health Asset Management, LLC 167,000 SH
- RENAISSANCE TECHNOLOGIES LLC 164,000 SH
- LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 132,272 SH
- RAYMOND JAMES FINANCIAL INC 117,482 SH
- STEMPOINT CAPITAL LP 96,273 SH
- HRT FINANCIAL LP 85,700 SH
- TD Asset Management Inc 73,146 SH
- FRED ALGER MANAGEMENT, LLC 71,967 SH
- Caption Management, LLC 67,000 SH
- Sixth Street Partners Management Company, L.P. 61,174 SH
- Vestal Point Capital, LP 53,439 SH
- Man Group plc 49,044 SH
- MANUFACTURERS LIFE INSURANCE COMPANY, THE 47,249 SH
- Artia Global Partners LP 42,080 SH
- Quinn Opportunity Partners LLC 40,000 SH
- FRANKLIN RESOURCES INC 35,267 SH
- Squarepoint Ops LLC 33,334 SH
- SummitTX Capital, L.P. 19,993 SH
- Ikarian Capital, LLC 16,500 SH
- MetLife Investment Management, LLC 14,940 SH
- Quantbot Technologies LP 10,735 SH
- DIVERSIFIED TRUST CO 10,022 SH
- K2 PRINCIPAL FUND, L.P. 10,000 SH
- Rosalind Advisors, Inc. 6,200 SH
- China Universal Asset Management Co., Ltd. 3,600 SH
- Persistent Asset Partners Ltd 782 SH
- NISA INVESTMENT ADVISORS, LLC 500 SH
- Quarry LP 192 SH
- Commonwealth Retirement Investments LLC 2 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Dellora Investments Master Fund LP Common Stock, $0.0001 par value per share | 5.5 | 2,061,000.00 | 10/02/2026 Filed 2026-10-09 | SCHEDULE 13G/AAmendment 5 | Open filing 0001943462-26-000008 Dispute this row |
| Dellora Investments LP Common Stock, $0.0001 par value per share | 6.4 | 2,400,000.00 | 10/02/2026 Filed 2026-10-09 | SCHEDULE 13G/AAmendment 5 | Open filing 0001943462-26-000008 Dispute this row |
| Kevin Pyun Common Stock, $0.0001 par value per share | 6.4 | 2,400,000.00 | 10/02/2026 Filed 2026-10-09 | SCHEDULE 13G/AAmendment 5 | Open filing 0001943462-26-000008 Dispute this row |
| RTW Investments, LP Common Stock, $0.0001 par value | 0.0 | 0.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001493215-26-000210 Dispute this row |
| Roderick Wong Common Stock, $0.0001 par value | 0.0 | 0.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001493215-26-000210 Dispute this row |
| BIOTECHNOLOGY VALUE FUND L P Common Stock, $0.0001 par value per share | 8.2 | 3,356,851.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000921895-26-003191 Dispute this row |
| BVF I GP LLC Common Stock, $0.0001 par value per share | 8.2 | 3,356,851.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000921895-26-003191 Dispute this row |
| BIOTECHNOLOGY VALUE FUND II LP Common Stock, $0.0001 par value per share | 2.0 | 769,485.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000921895-26-003191 Dispute this row |
| BVF II GP LLC Common Stock, $0.0001 par value per share | 2.0 | 769,485.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000921895-26-003191 Dispute this row |
| Biotechnology Value Trading Fund OS LP Common Stock, $0.0001 par value per share | 0 | 37.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000921895-26-003191 Dispute this row |
| BVF Partners OS Ltd. Common Stock, $0.0001 par value per share | 0 | 37.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000921895-26-003191 Dispute this row |
| BVF GP HOLDINGS LLC Common Stock, $0.0001 par value per share | 9.93 | 4,126,336.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000921895-26-003191 Dispute this row |
| BVF PARTNERS L P/IL Common Stock, $0.0001 par value per share | 9.99 | 4,150,818.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000921895-26-003191 Dispute this row |
| BVF INC/IL Common Stock, $0.0001 par value per share | 9.99 | 4,150,818.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000921895-26-003191 Dispute this row |
| LAMPERT MARK N Common Stock, $0.0001 par value per share | 9.99 | 4,150,818.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000921895-26-003191 Dispute this row |
| ADAR1 Capital Management, LLC Common Stock, $0.0001 par value per share | 16.4 | 7,447,000.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-128734 Dispute this row |
| Daniel Schneeberger Common Stock, $0.0001 par value per share | 16.4 | 7,447,000.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-128734 Dispute this row |
| Vestal Point Capital, LP Common Stock, par value $0.0001 per share | 0 | 0.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0000902664-26-004578 Dispute this row |
| Ryan Wilder Common Stock, par value $0.0001 per share | 0 | 0.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0000902664-26-004578 Dispute this row |
| JANUS HENDERSON GROUP Ltd. Common Stock | 0.0 | 0 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001274173-26-000268 Dispute this row |
| Sirenia Capital Management LP Common Stock, par value $0.0001 per share | 5.4 | 2,039,069.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0000919574-26-007956 Dispute this row |
| Alex Silverstein Common Stock, par value $0.0001 per share | 5.4 | 2,039,069.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0000919574-26-007956 Dispute this row |
| Adage Capital Management, L.P. Common Stock, par value $0.0001 per share | 2.26 | 857,270.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0000919574-26-007573 Dispute this row |
| Robert Atchinson Common Stock, par value $0.0001 per share | 2.26 | 857,270.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0000919574-26-007573 Dispute this row |
| Phillip Gross Common Stock, par value $0.0001 per share | 2.26 | 857,270.00 | 09/30/2026 Filed 2026-11-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0000919574-26-007573 Dispute this row |
| BlackRock, Inc. Common Stock | 7.5 | 2,804,788 | 09/30/2026 Filed 2026-10-27 | SCHEDULE 13G/AAmendment 1 | Open filing 0002012383-26-003851 Dispute this row |
| Millennium Management LLC Common Stock, par value $0.0001 per share | 3.6 | 1,362,730.00 | 09/30/2026 Filed 2026-10-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-116300 Dispute this row |
| Millennium Group Management LLC Common Stock, par value $0.0001 per share | 3.6 | 1,362,730.00 | 09/30/2026 Filed 2026-10-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-116300 Dispute this row |
| Israel A. Englander Common Stock, par value $0.0001 per share | 3.6 | 1,362,730.00 | 09/30/2026 Filed 2026-10-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-116300 Dispute this row |
| Sphera Funds Management Ltd. Common Stock, par value $0.0001 per share | 7.09 | 2,663,296.00 | 09/30/2026 Filed 2026-10-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001178913-26-004757 Dispute this row |
| Sphera Global Healthcare GP Ltd. Common Stock, par value $0.0001 per share | 7.09 | 2,663,296.00 | 09/30/2026 Filed 2026-10-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001178913-26-004757 Dispute this row |
| Sphera Global Healthcare Management LP Common Stock, par value $0.0001 per share | 7.09 | 2,663,296.00 | 09/30/2026 Filed 2026-10-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001178913-26-004757 Dispute this row |
| ING Groep N.V. Common Stock, $0.0001 par value per share | 0.00 | 0 | 09/03/2026 Filed 2026-09-11 | SCHEDULE 13G/AAmendment 1 | Open filing 0001140361-26-036327 Dispute this row |
| ING Capital Markets LLC Common Stock, $0.0001 par value per share | 0.00 | 0 | 09/03/2026 Filed 2026-09-11 | SCHEDULE 13G/AAmendment 1 | Open filing 0001140361-26-036327 Dispute this row |
| FMR LLC COMMON STOCK | 1.4 | 514,925.00 | 08/31/2026 Filed 2026-09-08 | SCHEDULE 13G/AAmendment 1 | Open filing 0000315066-26-002289 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 1.4 | 514,925.00 | 08/31/2026 Filed 2026-09-08 | SCHEDULE 13G/AAmendment 1 | Open filing 0000315066-26-002289 Dispute this row |
| ADAR1 Capital Management, LLC Common Stock, $0.0001 par value per share | 14.0 | 5,257,389.00 | 08/31/2026 Filed 2026-09-08 | SCHEDULE 13G | Open filing 0001104659-26-105941 Dispute this row |
| Daniel Schneeberger Common Stock, $0.0001 par value per share | 14.0 | 5,257,389.00 | 08/31/2026 Filed 2026-09-08 | SCHEDULE 13G | Open filing 0001104659-26-105941 Dispute this row |
| ING Groep N.V. Common Stock, $0.0001 par value per share | 7.05 | 2,639,666 | 08/19/2026 Filed 2026-08-27 | SCHEDULE 13G | Open filing 0001140361-26-034749 Dispute this row |
| ING Capital Markets LLC Common Stock, $0.0001 par value per share | 7.05 | 2,639,666 | 08/19/2026 Filed 2026-08-27 | SCHEDULE 13G | Open filing 0001140361-26-034749 Dispute this row |
| Sphera Funds Management Ltd. Common Stock, par value $0.0001 per share | 5.33 | 1,993,496.00 | 08/17/2026 Filed 2026-08-27 | SCHEDULE 13G | Open filing 0001178913-26-004262 Dispute this row |
| Sphera Global Healthcare GP Ltd. Common Stock, par value $0.0001 per share | 5.33 | 1,993,496.00 | 08/17/2026 Filed 2026-08-27 | SCHEDULE 13G | Open filing 0001178913-26-004262 Dispute this row |
| Sphera Global Healthcare Management LP Common Stock, par value $0.0001 per share | 5.33 | 1,993,496.00 | 08/17/2026 Filed 2026-08-27 | SCHEDULE 13G | Open filing 0001178913-26-004262 Dispute this row |
| Millennium Management LLC Common Stock, par value $0.0001 per share | 5.8 | 2,156,891.00 | 08/13/2026 Filed 2026-08-18 | SCHEDULE 13G | Open filing 0001104659-26-098450 Dispute this row |
| Millennium Group Management LLC Common Stock, par value $0.0001 per share | 5.8 | 2,156,891.00 | 08/13/2026 Filed 2026-08-18 | SCHEDULE 13G | Open filing 0001104659-26-098450 Dispute this row |
| Israel A. Englander Common Stock, par value $0.0001 per share | 5.8 | 2,156,891.00 | 08/13/2026 Filed 2026-08-18 | SCHEDULE 13G | Open filing 0001104659-26-098450 Dispute this row |
| Christopher Thomas Giordano Common Stock, $0.0001 par value per share | 4.32 | 1,690,606 | 07/31/2026 Filed 2026-07-31 | SCHEDULE 13D/AAmendment 1 | Open filing 0001193125-26-328603 Dispute this row |
| Vivo Opportunity Fund Holdings, L.P. Common Stock, $0.0001 par value per share | 9.0 | 3,458,327.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-090068 Dispute this row |
| Vivo Opportunity, LLC Common Stock, $0.0001 par value per share | 9.0 | 3,458,327.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-090068 Dispute this row |
| Perceptive Advisors LLC Common Stock, $0.0001 par value per share | 4.5 | 1,700,000 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-352650 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,615,281 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 32,368 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,123 |
Filings made before the SEC required XML are listed, not extracted.